Ares Management Corp <ARES.N>: RBC Raises Target Price to $168 From $162
ARES•Related News
Fresenius Kabi wins FDA approval for Dr. Reddy’s rituximab biosimilar in US
RDY•
Live Nation Entertainment Inc <LYV.N>: TD Cowen Raises Target Price To $194 From $177
LYV•
Tesla new registrations in Denmark rise 52% year-on-year in July
TSLA•
Global Markets-Oil slumps on hopes of Iran deal, yen firms after intervention
SPY•
Atkore Q3 sales beat on pricing strength, foreign exchange benefits
ATKR•